img

Global Irritable Bowel Syndrome Medication Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Irritable Bowel Syndrome Medication Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Irritable Bowel Syndrome Medication Market
Global Irritable Bowel Syndrome Medication market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Irritable Bowel Syndrome Medication industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Irritable Bowel Syndrome Medication market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Irritable Bowel Syndrome Medication market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bausch Health
Sucampo Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals
Salix Pharmaceuticals
lronwood Pharmaceuticals
GlaxoSmithKline
Allergan
Segment by Type
Irritable Bowel Syndrome with Constipation
lrritable Bowel Syndrome with Diarrhea
lrritable Bowel Syndrome with alternating Constipationand Diarrhea

Segment by Application


Hospitals
Clinics
Homecare Settings
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Irritable Bowel Syndrome Medication introduction, etc. Irritable Bowel Syndrome Medication Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Irritable Bowel Syndrome Medication
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Irritable Bowel Syndrome with Constipation
1.2.3 lrritable Bowel Syndrome with Diarrhea
1.2.4 lrritable Bowel Syndrome with alternating Constipationand Diarrhea
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare Settings
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome Medication Market Perspective (2018-2029)
2.2 Global Irritable Bowel Syndrome Medication Growth Trends by Region
2.2.1 Irritable Bowel Syndrome Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Irritable Bowel Syndrome Medication Historic Market Size by Region (2018-2024)
2.2.3 Irritable Bowel Syndrome Medication Forecasted Market Size by Region (2024-2029)
2.3 Irritable Bowel Syndrome Medication Market Dynamics
2.3.1 Irritable Bowel Syndrome Medication Industry Trends
2.3.2 Irritable Bowel Syndrome Medication Market Drivers
2.3.3 Irritable Bowel Syndrome Medication Market Challenges
2.3.4 Irritable Bowel Syndrome Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Irritable Bowel Syndrome Medication by Players
3.1.1 Global Irritable Bowel Syndrome Medication Revenue by Players (2018-2024)
3.1.2 Global Irritable Bowel Syndrome Medication Revenue Market Share by Players (2018-2024)
3.2 Global Irritable Bowel Syndrome Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Irritable Bowel Syndrome Medication, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Irritable Bowel Syndrome Medication Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Medication Revenue in 2022
3.5 Global Key Players of Irritable Bowel Syndrome Medication Head office and Area Served
3.6 Global Key Players of Irritable Bowel Syndrome Medication, Product and Application
3.7 Global Key Players of Irritable Bowel Syndrome Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome Medication Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome Medication Historic Market Size by Type (2018-2024)
4.2 Global Irritable Bowel Syndrome Medication Forecasted Market Size by Type (2024-2029)
5 Irritable Bowel Syndrome Medication Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome Medication Historic Market Size by Application (2018-2024)
5.2 Global Irritable Bowel Syndrome Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Irritable Bowel Syndrome Medication Market Size (2018-2029)
6.2 North America Irritable Bowel Syndrome Medication Market Size by Type
6.2.1 North America Irritable Bowel Syndrome Medication Market Size by Type (2018-2024)
6.2.2 North America Irritable Bowel Syndrome Medication Market Size by Type (2024-2029)
6.2.3 North America Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
6.3 North America Irritable Bowel Syndrome Medication Market Size by Application
6.3.1 North America Irritable Bowel Syndrome Medication Market Size by Application (2018-2024)
6.3.2 North America Irritable Bowel Syndrome Medication Market Size by Application (2024-2029)
6.3.3 North America Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
6.4 North America Irritable Bowel Syndrome Medication Market Size by Country
6.4.1 North America Irritable Bowel Syndrome Medication Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Irritable Bowel Syndrome Medication Market Size by Country (2018-2024)
6.4.3 North America Irritable Bowel Syndrome Medication Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Medication Market Size (2018-2029)
7.2 Europe Irritable Bowel Syndrome Medication Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome Medication Market Size by Type (2018-2024)
7.2.2 Europe Irritable Bowel Syndrome Medication Market Size by Type (2024-2029)
7.2.3 Europe Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
7.3 Europe Irritable Bowel Syndrome Medication Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome Medication Market Size by Application (2018-2024)
7.3.2 Europe Irritable Bowel Syndrome Medication Market Size by Application (2024-2029)
7.3.3 Europe Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
7.4 Europe Irritable Bowel Syndrome Medication Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome Medication Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Irritable Bowel Syndrome Medication Market Size by Country (2018-2024)
7.4.3 Europe Irritable Bowel Syndrome Medication Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Irritable Bowel Syndrome Medication Market Size (2018-2029)
8.2 China Irritable Bowel Syndrome Medication Market Size by Type
8.2.1 China Irritable Bowel Syndrome Medication Market Size by Type (2018-2024)
8.2.2 China Irritable Bowel Syndrome Medication Market Size by Type (2024-2029)
8.2.3 China Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
8.3 China Irritable Bowel Syndrome Medication Market Size by Application
8.3.1 China Irritable Bowel Syndrome Medication Market Size by Application (2018-2024)
8.3.2 China Irritable Bowel Syndrome Medication Market Size by Application (2024-2029)
8.3.3 China Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Irritable Bowel Syndrome Medication Market Size (2018-2029)
9.2 Asia Irritable Bowel Syndrome Medication Market Size by Type
9.2.1 Asia Irritable Bowel Syndrome Medication Market Size by Type (2018-2024)
9.2.2 Asia Irritable Bowel Syndrome Medication Market Size by Type (2024-2029)
9.2.3 Asia Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
9.3 Asia Irritable Bowel Syndrome Medication Market Size by Application
9.3.1 Asia Irritable Bowel Syndrome Medication Market Size by Application (2018-2024)
9.3.2 Asia Irritable Bowel Syndrome Medication Market Size by Application (2024-2029)
9.3.3 Asia Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
9.4 Asia Irritable Bowel Syndrome Medication Market Size by Region
9.4.1 Asia Irritable Bowel Syndrome Medication Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Irritable Bowel Syndrome Medication Market Size by Region (2018-2024)
9.4.3 Asia Irritable Bowel Syndrome Medication Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome Medication Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.1.5 Bausch Health Recent Developments
11.2 Sucampo Pharmaceuticals
11.2.1 Sucampo Pharmaceuticals Company Details
11.2.2 Sucampo Pharmaceuticals Business Overview
11.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.2.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.2.5 Sucampo Pharmaceuticals Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Irritable Bowel Syndrome Medication Introduction
11.3.4 Abbott Laboratories Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.3.5 Abbott Laboratories Recent Developments
11.4 Lexicon Pharmaceuticals
11.4.1 Lexicon Pharmaceuticals Company Details
11.4.2 Lexicon Pharmaceuticals Business Overview
11.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.4.4 Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.4.5 Lexicon Pharmaceuticals Recent Developments
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Details
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.5.4 Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.5.5 Salix Pharmaceuticals Recent Developments
11.6 lronwood Pharmaceuticals
11.6.1 lronwood Pharmaceuticals Company Details
11.6.2 lronwood Pharmaceuticals Business Overview
11.6.3 lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.6.4 lronwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.6.5 lronwood Pharmaceuticals Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Irritable Bowel Syndrome Medication Introduction
11.7.4 GlaxoSmithKline Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Irritable Bowel Syndrome Medication Introduction
11.8.4 Allergan Revenue in Irritable Bowel Syndrome Medication Business (2018-2024)
11.8.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Irritable Bowel Syndrome with Constipation
Table 3. Key Players of lrritable Bowel Syndrome with Diarrhea
Table 4. Key Players of lrritable Bowel Syndrome with alternating Constipationand Diarrhea
Table 5. Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Irritable Bowel Syndrome Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Irritable Bowel Syndrome Medication Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Medication Market Share by Region (2018-2024)
Table 9. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Medication Market Share by Region (2024-2029)
Table 11. Irritable Bowel Syndrome Medication Market Trends
Table 12. Irritable Bowel Syndrome Medication Market Drivers
Table 13. Irritable Bowel Syndrome Medication Market Challenges
Table 14. Irritable Bowel Syndrome Medication Market Restraints
Table 15. Global Irritable Bowel Syndrome Medication Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome Medication Revenue Share by Players (2018-2024)
Table 17. Global Top Irritable Bowel Syndrome Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Medication as of 2022)
Table 18. Global Irritable Bowel Syndrome Medication Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Medication Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Irritable Bowel Syndrome Medication, Headquarters and Area Served
Table 21. Global Key Players of Irritable Bowel Syndrome Medication, Product and Application
Table 22. Global Key Players of Irritable Bowel Syndrome Medication, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome Medication Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Medication Revenue Market Share by Type (2018-2024)
Table 26. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Irritable Bowel Syndrome Medication Revenue Market Share by Type (2024-2029)
Table 28. Global Irritable Bowel Syndrome Medication Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome Medication Revenue Share by Application (2018-2024)
Table 30. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Irritable Bowel Syndrome Medication Revenue Share by Application (2024-2029)
Table 32. North America Irritable Bowel Syndrome Medication Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Irritable Bowel Syndrome Medication Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome Medication Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Irritable Bowel Syndrome Medication Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Irritable Bowel Syndrome Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Irritable Bowel Syndrome Medication Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Irritable Bowel Syndrome Medication Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Irritable Bowel Syndrome Medication Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Irritable Bowel Syndrome Medication Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Irritable Bowel Syndrome Medication Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Irritable Bowel Syndrome Medication Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Irritable Bowel Syndrome Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Irritable Bowel Syndrome Medication Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Irritable Bowel Syndrome Medication Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Irritable Bowel Syndrome Medication Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Irritable Bowel Syndrome Medication Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Irritable Bowel Syndrome Medication Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Irritable Bowel Syndrome Medication Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Irritable Bowel Syndrome Medication Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Irritable Bowel Syndrome Medication Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Irritable Bowel Syndrome Medication Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Irritable Bowel Syndrome Medication Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Irritable Bowel Syndrome Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Irritable Bowel Syndrome Medication Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Irritable Bowel Syndrome Medication Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size by Country (2024-2029) & (US$ Million)
Table 64. Bausch Health Company Details
Table 65. Bausch Health Business Overview
Table 66. Bausch Health Irritable Bowel Syndrome Medication Product
Table 67. Bausch Health Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 68. Bausch Health Recent Developments
Table 69. Sucampo Pharmaceuticals Company Details
Table 70. Sucampo Pharmaceuticals Business Overview
Table 71. Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 72. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 73. Sucampo Pharmaceuticals Recent Developments
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Irritable Bowel Syndrome Medication Product
Table 77. Abbott Laboratories Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 78. Abbott Laboratories Recent Developments
Table 79. Lexicon Pharmaceuticals Company Details
Table 80. Lexicon Pharmaceuticals Business Overview
Table 81. Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 82. Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 83. Lexicon Pharmaceuticals Recent Developments
Table 84. Salix Pharmaceuticals Company Details
Table 85. Salix Pharmaceuticals Business Overview
Table 86. Salix Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 87. Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 88. Salix Pharmaceuticals Recent Developments
Table 89. lronwood Pharmaceuticals Company Details
Table 90. lronwood Pharmaceuticals Business Overview
Table 91. lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 92. lronwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 93. lronwood Pharmaceuticals Recent Developments
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Irritable Bowel Syndrome Medication Product
Table 97. GlaxoSmithKline Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 98. GlaxoSmithKline Recent Developments
Table 99. Allergan Company Details
Table 100. Allergan Business Overview
Table 101. Allergan Irritable Bowel Syndrome Medication Product
Table 102. Allergan Revenue in Irritable Bowel Syndrome Medication Business (2018-2024) & (US$ Million)
Table 103. Allergan Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Irritable Bowel Syndrome Medication Market Share by Type: 2022 VS 2029
Figure 3. Irritable Bowel Syndrome with Constipation Features
Figure 4. lrritable Bowel Syndrome with Diarrhea Features
Figure 5. lrritable Bowel Syndrome with alternating Constipationand Diarrhea Features
Figure 6. Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Irritable Bowel Syndrome Medication Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Homecare Settings Case Studies
Figure 11. Irritable Bowel Syndrome Medication Report Years Considered
Figure 12. Global Irritable Bowel Syndrome Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Irritable Bowel Syndrome Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Irritable Bowel Syndrome Medication Market Share by Region: 2022 VS 2029
Figure 15. Global Irritable Bowel Syndrome Medication Market Share by Players in 2022
Figure 16. Global Top Irritable Bowel Syndrome Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Medication as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Medication Revenue in 2022
Figure 18. North America Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
Figure 20. North America Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
Figure 21. North America Irritable Bowel Syndrome Medication Market Share by Country (2018-2029)
Figure 22. United States Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Irritable Bowel Syndrome Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
Figure 26. Europe Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
Figure 27. Europe Irritable Bowel Syndrome Medication Market Share by Country (2018-2029)
Figure 28. Germany Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Irritable Bowel Syndrome Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
Figure 36. China Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
Figure 37. Asia Irritable Bowel Syndrome Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
Figure 39. Asia Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
Figure 40. Asia Irritable Bowel Syndrome Medication Market Share by Region (2018-2029)
Figure 41. Japan Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Irritable Bowel Syndrome Medication Market Share by Country (2018-2029)
Figure 51. Brazil Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Irritable Bowel Syndrome Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 58. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 59. Abbott Laboratories Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 60. Lexicon Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 61. Salix Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 62. lronwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 64. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries